Odyssey Therapeutics, Inc.
NASDAQODTX utilization surges to 95.18%, near the 52-week peak of 100%, signaling acute scarcity of shares available to borrow as short interest remains contested.
Short interest % of float, cost to borrow, utilization, and put/call ratio for ODTX are part of the ORTEX premium tier. Sign up to read the live numbers alongside the analysis.
Snapshot as of 21 Jun 2026
No long-form analysis yet for ODTX. Pulse alerts and the live data picture are available on ORTEX.
Open ODTX on ORTEX →Short interest updated daily, real-time options flow, analyst consensus deltas, 13F positioning, ORTEX Alpha signals, and every article ORTEX publishes for ODTX — free to start on ORTEX.
Sign up for free →Open ODTX on ORTEX